| Literature DB >> 33924574 |
Jeerawan Hinkaew1, Amornrat Aursalung1, Yuraporn Sahasakul1,2, Nattapol Tangsuphoom1,2, Uthaiwan Suttisansanee1,2.
Abstract
Date palm fruit (Phoenix dactylifera L.) is commonly consumed around the world and has recently become an economical crop in Eastern Thailand, especially the Barhi cultivar that can be consumed as fresh fruit. To maintain genetic qualities, date palm is populated through cell culture. This leads to high production costs, while access to this technique is limited. Increasing date palm population by simple seed planting is currently of interest as an alternative for local farmers. Nevertheless, information on nutritive values, bioactive compounds, and health-promoting bioactivities of seed originating from date palm fruit is unavailable. Effects of different planting origins (cell culture origin (CO) and seed origin (SO)) of date palm fruits at the Khalal stage of Barhi cultivar were investigated for nutritive values, bioactive compounds, and in vitro health-promoting properties via key enzyme inhibitions against obesity (lipase), diabetes (α-amylase, α-glucosidase, and dipeptidyl peptidase-IV), Alzheimer's disease (cholinesterases and β-secretase), and hypertension (angiotensin-converting enzyme). Waste seeds as a by-product from date palm production were also examined regarding these properties to increase seed marketing opportunities for future food applications and other health-related products. CO and SO exhibited insignificant differences in energy, fat, and carbohydrate contents. SO had higher protein, dietary fiber, vitamin A, vitamin E, and calcium contents than CO, while CO contained higher contents of fructose, glucose and maltose. Higher phenolic contents in SO led to greater enzyme inhibitory activities than CO. Interestingly, seeds of date palm fruits mostly contained higher nutritive values than the flesh. No carotenoids were detected in seeds but higher phenolic contents resulted in greater enzyme inhibitory activities than recorded for fruit flesh. Results suggest that appropriate planting of date palm can support the development of novel date palm fruit products, leading to expansion of economic opportunities and investment in date palm fruit agriculture.Entities:
Keywords: Phoenix dactylifera L.; carotenoids; cell culture origin; in vitro health properties; nutritional compositions; phenolics; seed origin
Mesh:
Substances:
Year: 2021 PMID: 33924574 PMCID: PMC8069938 DOI: 10.3390/molecules26082245
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Nutritive values of flesh and seed of cell culture originated (CO) and seed originated (SO) date palm fruits at Khalal stage of Barhi cultivar.
| Nutrients | Nutritive Value (Per 100 g Dry Weight) | |||
|---|---|---|---|---|
| Flesh | Seed | |||
| CO | SO | CO | SO | |
|
| 388.07 ± 2.41 ** | 385.13 ± 0.76 ** | 441.21 ± 2.42 * | 432.85 ± 1.73 |
|
| 2.68 ± 0.08 *,** | 4.64 ± 0.14 ** | 4.88 ± 0.09 * | 6.09 ± 0.13 |
|
| 0.19 ± 0.04 ** | 0.00 ± 0.00 ** | 9.24 ± 0.49 * | 7.73 ± 0.35 |
|
| 93.47 ± 0.35 *,** | 91.64 ± 0.27 ** | 84.64 ± 0.53 | 84.73 ± 0.32 |
|
| 16.62 ± 0.44 *,** | 23.44 ± 1.34 ** | 84.14 ± 2.95 | 81.95 ± 0.98 |
|
| 2.37 ± 0.04 ** | 4.13 ± 0.97 ** | 1.08 ± 0.47 | 1.55 ± 0.04 |
|
| 14.24 ± 0.44 *,** | 19.30 ± 0.60 ** | 83.05 ± 2.88 | 80.41 ± 0.99 |
|
| 3.46 ± 0.29 ** | 3.72 ± 0.19 ** | 1.25 ± 0.06 * | 1.45 ± 0.02 |
|
| 74.25 ± 2.37 *,** | 62.50 ± 2.77 ** | 3.60 ± 0.04 | 3.58 ± 0.13 |
|
| 35.63 ± 1.26 *,** | 29.57 ± 1.73 ** | 1.87 ± 0.08 | 1.83 ± 0.11 |
|
| 36.53 ± 1.14 *,** | 32.93 ± 1.04 ** | 1.73 ± 0.09 | 1.75 ± 0.04 |
|
| 1.58 ± 0.08 *,** | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
|
| 0.52 ± 0.03 *,** | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 |
|
| ||||
|
| 10.06 ± 0.18 *,** | 30.19 ± 0.93 ** | 1.62 ± 1.14 | 2.20 ± 2.33 |
|
| <LOD | <LOD | <LOD | <LOD |
|
| 0.59 ± 0.03 *,** | 23.64 ± 0.88 ** | 0.06 ± 0.00 | 0.07 ± 0.01 |
|
| ND | ND | ND | ND |
|
| ||||
|
| 63.92 ± 13.69 *,** | 107.12 ± 3.99 ** | 30.25 ± 0.64 * | 34.38 ± 1.22 |
|
| 115.04 ± 6.43 *,** | 185.28 ± 38.09 | 156.33 ± 12.26 | 182.24 ± 13.65 |
|
| 52.75 ± 3.00 *,** | 74.94 ± 6.68 ** | 20.21 ± 4.92 | 16.24 ± 8.56 |
|
| 1051.56 ± 68.09 ** | 1091.53 ± 52.52 ** | 321.79 ± 55.1 | 312.16 ± 38.48 |
|
| 44.36 ± 2.26 *,** | 49.74 ± 1.00 ** | 68.73 ± 1.61 * | 74.81 ± 1.16 |
|
| 0.87 ± 0.05 *,** | 0.72 ± 0.08 ** | 1.06 ± 0.05 | 1.15 ± 0.20 |
|
| 0.29 ± 0.05 *,** | 0.46 ± 0.06 | 0.84 ± 0.02 | 0.55 ± 0.41 |
All data were expressed as mean ± standard deviation (SD) of triplicate experiments (n = 3). SDF: soluble dietary fiber; IDF: insoluble dietary fiber; ND: not detected; vitamin A presented as µg β-carotene; vitamin E presented as mg α-tocopherol; < LOD: Limit of detection at 0.05 µg/100 g; * showed significant difference (p < 0.05) between values in the same fruit part of cell culture originated (CO) and seed originated (SO) date palm fruit using unpaired t-test; ** showed significant difference (p < 0.05) between values in flesh and seed of the same originated date palm fruit using unpaired t-test.
Total phenolic contents (TPCs) and total flavonoid contents (TFCs), phenolic profiles (phenolic acids and flavonoids), and carotenoid profiles of flesh and seed of cell culture originated (CO) and seed originated (SO) date palm fruits at Khalal stage of Barhi cultivars.
| Bioactive | Flesh | Seed | ||
|---|---|---|---|---|
| CO | SO | CO | SO | |
|
| 2.59 ± 0.11 *,** | 3.94 ± 0.17 ** | 10.76 ± 0.97 * | 18.41 ± 1.83 |
|
| 1.95 ± 0.17 *,** | 4.01 ± 0.15 ** | 7.43 ± 0.30 * | 13.68 ± 1.14 |
|
| ||||
|
| ND | ND | 0.70 ± 0.04 | 0.74 ± 0.03 |
|
| 6.12 ± 0.38 *,** | 8.19 ± 0.20 ** | 7.00 ± 0.13 * | 4.94 ± 0.35 |
|
| 0.16 ± 0.00 *,** | 3.56 ± 0.10 ** | 3.31 ± 0.04 | 3.27 ± 0.06 |
|
| 4.11 ± 0.35 * | 3.19 ± 0.10 | 3.84 ± 0.06 * | 3.18 ± 0.10 |
|
| 1.80 ± 0.02 *,** | 1.52 ± 0.07 ** | 1.35 ± 0.16 | 1.15 ± 0.04 |
|
| 7.91 ± 0.10 *,** | 9.71 ± 0.19 ** | 1.75 ± 0.03 * | 1.11 ± 0.02 |
|
| 2.06 ± 0.15 *,** | 6.60 ± 0.06 ** | 0.51 ± 0.02 * | 0.36 ± 0.02 |
|
| ||||
|
| 4.72 ± 0.10 * | 3.53 ± 0.04 | ND | ND |
|
| 0.71 ± 0.00 *,** | 1.93 ± 0.01 ** | 0.94 ± 0.02 * | 1.14 ± 0.05 |
|
| ND | ND | 1.05 ± 0.01 * | 2.48 ± 0.07 |
|
| 3.62 ± 0.03 *,** | 2.13 ± 0.02 ** | 0.40 ± 0.01 * | 0.56 ± 0.02 |
|
| 0.80 ± 0.02 *,** | 0.36 ± 0.01 ** | 0.31 ± 0.00 | 0.32 ± 0.02 |
|
| 4.51 ± 0.08 *,** | 5.76 ± 0.03 ** | 2.93 ± 0.03 * | 4.03 ± 0.02 |
|
| ||||
|
| 205.96 ± 5.01 * | 1076.00 ± 25.68 | ND | ND |
|
| 51.76 ± 2.11 * | 99.31 ± 6.93 | ND | ND |
|
| 153.81 ± 1.29 * | 298.80 ± 4.11 | ND | ND |
|
| 96.15 ± 1.87 * | 218.90 ± 6.78 | ND | ND |
All data were expressed as mean ± standard deviation (SD) of triplicate experiments (n = 3). GAE: gallic acid equivalent; QE: quercetin equivalent; DW: dry weight; ND: not detected; * showed significant difference (p < 0.05) between values in the same fruit part of cell culture originated (CO) and seed originated (SO) date palm fruits using unpaired t-test; ** showed significant difference (p < 0.05) between values in flesh and seed of the same originated date palm fruit using unpaired t-test.
Enzyme inhibitory activities of flesh and seed of cell culture originated (CO) and seed originated (SO) date palm fruits at Khalal stage of Barhi cultivars.
| Enzyme Reactions | Enzyme Inhibitory Activities (%Inhibition) | |||
|---|---|---|---|---|
| Flesh | Seed | |||
| CO | SO | CO | SO | |
|
| 5.76 ± 0.24 *,** | 4.72 ± 0.38 ** | 20.66 ± 1.61 * | 77.14 ± 7.51 |
|
| ND | ND | 63.51 ± 3.66 * | 70.14 ± 3.09 |
|
| 50.52 ± 5.03 * | 44.64 ± 0.87 | 60.38 ± 5.81 * | 52.33 ± 5.03 |
|
| ND | 4.39 ± 0.56 | ND | ND |
|
| ND | 23.49 ± 1.60 | 67.97 ± 4.56 * | 49.49 ± 3.29 |
|
| ND | 31.20 ± 3.05 | 46.80 ± 3.34 * | 27.19 ± 1.04 |
|
| 75.05 ± 1.25 *,** | 70.73 ± 0.44 ** | 39.23 ± 3.52 * | 24.50 ± 2.05 |
|
| 20.68 ± 0.60 *,** | 85.07 ± 0.30 ** | 58.69 ± 0.93 | 61.36 ± 4.95 |
All data are expressed as mean ± standard deviation (SD) of triplicate experiments (n = 3). DPP-IV: dipeptidyl peptidase-IV; AChE: acetylcholinesterase; BChE: butyrylcholinesterase; BACE-1: β-secreatse; ACE: angiotensin-converting enzyme; ND: not detected; 1concentration of flesh and seed extracts = 2.5 mg/mL; 2concentration of flesh and seed extracts = 25 mg/mL; 3concentration of flesh extract = 2.5 mg/mL and of seed extracts = 0.075 mg/mL; 4concentration of flesh and seed extracts = 12.5 mg/mL; 5concentration of flesh extract = 20 mg/mL and of seed extracts = 2 mg/mL; 6concentration of flesh extract = 20 mg/mL and of seed extracts = 0.2 mg/mL; 7concentration of flesh and seed extracts = 20 mg/mL; 8concentration of flesh and seed extracts = 0.55 mg/mL; * showed significant difference (p < 0.05) between values in the same fruit part of cell culture originated (CO) and seed originated (SO) date palm fruits using unpaired t-test; ** showed significant difference (p < 0.05) between values in flesh and seed of the same originated date palm fruit using unpaired t-test.
High performance liquid chromatography (HPLC) conditions to determine phenolics.
| Time (min) | Flow Rate (mL/min) | Solvent A (%) | Solvent B (%) | Solvent C (%) |
|---|---|---|---|---|
| 0 | 0.6 | 90 | 6 | 4 |
| 5 | 0.6 | 85 | 9 | 6 |
| 30 | 0.6 | 71 | 17.4 | 11.6 |
| 60 | 0.6 | 0 | 85 | 15 |
| 61 | 0.6 | 90 | 6 | 4 |
| 66 | 0.6 | 90 | 6 | 4 |
Solvent A = Milli-Q water containing 0.05% (v/v) trifluoroacetic acid (TFA); solvent B = methanol containing 0.05% (v/v) TFA; solvent C = acetonitrile containing 0.05% (v/v) TFA.
High performance liquid chromatography (HPLC) conditions to determine carotenoids.
| Time (min) | Flow rate (mL/min) | Solvent A (%) | Solvent B (%) |
|---|---|---|---|
| 0 | 0.6 | 20 | 80 |
| 1 | 0.6 | 20 | 80 |
| 10 | 0.6 | 40 | 60 |
| 20 | 0.6 | 60 | 40 |
| 25 | 0.6 | 75 | 25 |
| 30 | 0.6 | 75 | 25 |
| 32 | 0.6 | 20 | 80 |
| 37 | 0.6 | 20 | 80 |
Solvent A = absolute methyl tert-butyl ether (MtBE); solvent B = methanol containing 2% (v/v) ammonium acetate.
The compositions, types of assay, and detecting wavelengths of the enzyme inhibitory assays.
| Assay | Enzyme | Substrate | Indicator | Inhibitor | Assay Type | Detecting Wavelength |
|---|---|---|---|---|---|---|
| Lipase | 100 µL of 0.01 mg/mL | 50 µL of 0.2 mM 5-5′-dithiobis(2-nitrobenzoic- | 10 µL of 16 mM DTNB | 40 µL of extract | Kinetics | 412 nm |
| α-Amylase | 100 µL of 30 mg/mL porcine pancreatic α-amylase (type VII, ≥ 10 unit/mg) | 50 µL of 30 mM | 50 µL of extract | Kinetics | 405 nm | |
| α-Glucosidase | 100 µL of 0.1 U/mL | 50 µL of 2 mM | 50 µL of extract | Kinetics | 405 nm | |
| DPP-IV | 100 µL of 0.01 U/mL human dipeptidyl peptidase-IV (recombinant, ≥ 10 units/mg) | 50 µL of 6 mM Gly-Pro- | 50 µL of extract | Kinetics | 405 nm | |
| AChE | 100 μL of 20 ng | 40 μL of 0.8 mM acetylthiocholine | 10 µL of 16 mM DTNB | 40 µL of extract | Kinetics | 412 nm |
| BChE | 100 µL of 0.5 µg/mL equine serum BChE (≥ 10 units/mg) | 50 µL of 0.4 mM butyrylthiocholine | 10 µL of 16 mM DTNB | 40 µL of extract | Kinetics | 412 nm |
| BACE-1 | a BACE-1 FRET assay kit | 20 µL of extract | End-point | λex = 320 nm, λem = 405 nm | ||
| ACE | 3 µL of 0.5 U/mL rabbit lung ACE (≥ 2 unit/mg) | 30 µL of 3 mM hippuryl-histidyl-leucine | 15 µL of 20 mg/mL PDA | 50 µL of extract | End-point | λex = 360 nm, λem = 485 nm |
DPP-IV: dipeptidyl peptidase-IV; AChE: acetylcholinesterase; BChE: butyrylcholinesterase; BACE-1: β-secretase; ACE: angiotensin-converting enzyme; FRET: fluorescence resonance energy transfer; DTNB: 5,5′-dithiobis(2-nitrobenzoic acid); PDA: o-phthaldialdehyde.